Article Archive
2782 articles · newest first
Sep 16, 2026 · 2 min read
JUSTPLANNING is selling all three of its solar plants to Tokyu Fudosan and booking a ¥293mn gain that lifts its net-profit forecast 39.6% to ¥670mn, even though the sale itself trims sales and operating profit and ends the company's entire solar segment from October 1.
Sep 16, 2026 · 2 min read
Kameda Seika will hand its full 49% stake in a loss-making Indian rice-cracker venture to majority partner LT Foods, ending a nine-year attempt to build the category there, with the sale price undisclosed and completion due in late October.
Sep 16, 2026 · 2 min read
To comply with a farmland law that bars non-farmers from majority voting control, Fujita Corporation is taking only 40% of the vote in a Hokkaido dairy farm it is buying for about ¥139mn, while non-voting preferred shares hand it 99.4% of the economics.
Sep 16, 2026 · 2 min read
Under a sponsor agreement signed September 16, Ledax will pay ¥670mn for full ownership of a new company that inherits Harika's roughly 100 stores and 450 corporate clients, while Harika's bank borrowings stay with the renamed original entity and closing is targeted for January 5, 2027.
Sep 16, 2026 · 2 min read
Kringle Pharma raised its annual sales guidance and narrowed its projected loss for the year to September 2026 after signing an exclusive Japan licensing deal with Maruishi Pharmaceutical for an experimental vocal-fold-scar treatment, under which it will record a ¥100 million upfront fee as revenue this fiscal year, with roughly half of the improved loss forecast coming instead from ¥108 million of development spending that shifted into next year.
Sep 16, 2026 · 2 min read
Owners of specified buildings in Japan would face a new triennial test for PFOS and PFOA in drinking-water supplies if a draft health-ministry ordinance, open for comment until October 15, takes effect as planned in May 2027.
Sep 16, 2026 · 2 min read
Shionogi cleared a Japanese approval adding a booster dose to its Omicron JN.1 COVID-19 vaccine, completing the technical groundwork for supplying future season-matched shots, but the approved formulation itself won't be sold because it doesn't match the strain designated for the 2026-2027 season.
Sep 16, 2026 · 2 min read
Shionogi and Torii Pharmaceutical secured Japanese approval to prescribe a 0.5% version of their non-steroid eczema cream to children under 12, backed by a trial in patients aged 2 to under 12 showing it beat plain vehicle cream over eight weeks with good long-term tolerability.
Sep 16, 2026 · 2 min read
Japan's financial regulator finalized a new supervisory checkpoint asking whether investment-trust managers take reasonable steps to match liquidity, such as setting redemption terms to the liquidity of the assets they hold or introducing a variable trust-property reserve, effective October 2027, after a public comment argued the change does nothing to curb high fees charged to ordinary savers.
Sep 16, 2026 · 2 min read
Audiostock, the Okayama-based operator of the Audiostock stock-music licensing platform, listed on the Tokyo Stock Exchange Growth Market on September 16, 2026, after swinging from an operating loss three years ago to a 25.3% margin on ¥1.51bn in revenue; the company now guides for 16% revenue growth but a 25.6% drop in net profit this year as a one-off tax benefit unwinds.
Sep 16, 2026 · 2 min read
Three Integral-linked funds that held 85% of interior-fit-out maker Oliver's votes fell to zero percent on its Tokyo Standard market debut, though millions of shares remain on loan to Nomura until mid-October and Oliver is guiding for an 8.5% revenue rise with a 70% payout ratio this year.
Sep 16, 2026 · 1 min read
A fire that burned power cables serving reheating-furnace equipment at Nakayama Steel Works' Osaka plant has stopped the hot-rolling mill, though no one was hurt and downstream processing continues normally.
Sep 16, 2026 · 2 min read
DKK has appointed three outside experts to check whether a ¥912mn inventory valuation loss booked in the year to March 2026 should have been recorded in the prior fiscal year or the September 2025 interim period, even as the company insists its original accounting was correct.
Sep 16, 2026 · 2 min read
An auditor's refusal to give an opinion on ESPOIR's financial statements has triggered a mandatory Nagoya Stock Exchange delisting, with shares trading under a delisting flag until October 16 before formal removal on October 17, 2026.
Sep 16, 2026 · 2 min read
Nomura Europe Finance disclosed that its dollar-hedged Tokyo REIT exchange-traded note has not traded since August 5, 2026, so the quoted ¥24,690 price is frozen even as the note's redemption value has run 5 to 7 percent below it for seven straight sessions, peaking at a 7.26% gap on September 11.
Sep 16, 2026 · 2 min read
Japan Bank for International Cooperation will lend up to 1,672,100 thousand Thai baht, part of a 2,390,000 thousand baht syndicate with private banks, to help Inaba Foods' Thai subsidiary build a new pet food factory serving more than 80 export markets.
Sep 16, 2026 · 1 min read
Foreign nationals holding qualifications as dental technicians or speech-language-hearing therapists could gain access to Japan's Medical residence status under a draft rule now open for public comment until October 15, with the agency citing growing regional medical needs from an aging patient base and targeting a November effective date.
Sep 16, 2026 · 2 min read
Japan's FSA will treat a subsidiary's bond solicitation as the issuer's own from September 16, but the subsidiary has to guarantee repayment and supply backup funds itself rather than outsourcing either job, and the agency declined requests to spell out the equivalence test any further than the ordinance text already does.
Sep 16, 2026 · 3 min read
Japan's Consumer Affairs Agency wants chat and DM sales pitches to carry the same disclosure, cooling-off and re-solicitation bans as phone sales, alongside a crackdown on subscription-trap checkout screens and bait pricing for callout repair services, with public comment open until October 31, 2026.
Sep 16, 2026 · 3 min read
Eisai's newly approved subcutaneous Leqembi pen lets patients self-inject weekly at home instead of visiting a clinic every two weeks for IV infusion, but a Central Social Insurance Medical Council review and listing on the injectable drug list must happen first, and Eisai says the approval's effect on its coming-year earnings forecast is minor.
Sep 16, 2026 · 2 min read
METI has certified Central Glass's plan to build new anhydrous hydrofluoric acid capacity at its Ube plant, unlocking as much as ¥17.6bn in subsidy under Japan's economic-security law, though the company says investment details and the near-term earnings impact remain modest.
Sep 16, 2026 · 2 min read
Oasis Management's SMS holding climbed to 26.97% from 25.93% in a filing that also formalizes proposals on director dismissals, asset sales, a business exit, and a possible delisting or change-of-control transaction, though the filing does not show SMS having agreed to or acted on any of them.
Sep 16, 2026 · 2 min read
Core private-sector machinery orders, which exclude ships and electric-power orders, fell 3.7% in July from June, while total machinery orders fell a steeper 5.5%, according to the Cabinet Office's seasonally adjusted survey of 280 manufacturers.
Sep 16, 2026 · 3 min read
With interest rates rising, Japan's markets and banking regulator is turning its year-ahead priorities toward deposit-rate competition, insurer misconduct, unregistered crypto exchanges and stakebuilding moves designed to dodge disclosure rules, according to priorities the FSA published this week.